ATS Medical, Inc. 

(Public, NASDAQ:ATSI)   Watch this stock   
Find more results for ATSI
Nov 10, 2009
CanaccordAdams Cardiovascular Conference - Webcast
Nov 2, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 2, 2009
Q3 2009 Earnings Release
Sep 22, 2009
UBS Global Life Sciences Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q4 (Oct '09) 2008
Net profit margin -5.18% -29.38%
Operating margin -3.09% -25.12%
EBITD margin - -16.57%
Return on average assets -3.72% -17.51%
Return on average equity -5.27% -27.72%
Employees 301 -

Address

3905 Annapolis Lane N. Suite 105
Minneapolis, MN 55447
United States - Map
+1-763-5537736 (Phone)
+1-763-5572244 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

ATS Medical, Inc. discussions

  View all discussions »

Description

ATS Medical, Inc. (ATS) develops, manufactures and markets medical devices for the treatment of structural heart disease. Product offerings include devices for the treatment of structural heart disease with a focus on heart valve therapy and the surgical treatment of cardiac arrhythmias. Heart valve therapy products consist of mechanical and tissue heart valves and heart valve repair products. Surgical arrhythmia therapy products consist of cryotherapy products for the ablation of cardiac arrhythmias. During the year ended December 31, 2008, sales of mechanical heart valves represented approximately 65% of the Company’s revenue.

Officers and directors

Michael D. Dale
Chairman of the Board, President, Chief Executive Officer
Age: 49
Bio & Compensation - Reuters
Michael R. Kramer
Chief Financial Officer
Bio & Compensation - Reuters
Craig A. Swandal
Vice President - Operations
Bio & Compensation - Reuters
Thaddeus Coffindaffer
Vice President - Sales
Bio & Compensation - Reuters
Michael E. Reinhardt
Vice President - Marketing
Bio & Compensation - Reuters
Astrid Marie Berthe
Vice President - Regulatory Affairs and Quality Assurance
Bio & Compensation - Reuters
David R. Elizondo
Vice President - Research, Development and Clinical Affairs
Bio & Compensation - Reuters
Eric W. Sivertson
Director
Age: 58
Bio & Compensation - Reuters
Robert E. Munzenrider
Director
Age: 64
Bio & Compensation - Reuters
Steven M. Anderson
Director
Age: 46
Bio & Compensation - Reuters